Ziprasidone (or GEODON®) is mainly prescribed to treat schizophrenia and bipolar disorder.
Class: Atypical (AAP)
FDA Approval: 2001
Dosage Forms: 20 mg, 40 mg, 60 mg, 80 mg
Biological Half-life: 7-10 hours
Side Effects: Dizziness, headache, hypersalivation/dry mouth, weight gain, movement problems
Routes of Administration: Oral, IM
Pregnancy Category: C (US)